Riskpilot← Back to searchSign inGet full accessPHARMA HOLDING ApS
APSActiveCVR 32559174Herlev Hovedgade 195AFund management activities · NACE 6630Est. 2009— employees
Revenue 2024
DKK 0
EBITDA margin
—
-776% vs 2023
Equity ratio
83.2%
Financial strength
Net profit 2024
DKK -2,1M
+1% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -16K | -776% |
| Net profit | DKK -2,1M | +1% |
| Total assets | DKK 2,1M | -50% |
| Equity | DKK 1,7M | -54% |
| Employees | — | — |
Legal name
PHARMA HOLDING ApS
CVR number
32559174
Legal form
Anpartsselskab
NACE code
6630 · Fund management activities
Founded
3. november 2009
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Formueforvaltning
Address
Herlev Hovedgade 195A
Phone
+4521695777
Email
anni@jeg-er.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | -14 | — | — | — | — | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -3 | 1 | 0 | 0 | -14 | -0 | -4 | -5 | -52 | -12 | -14 | -2 | -16 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3 | 1 | 0 | 0 | -14 | -0 | -4 | -5 | -52 | -12 | -14 | -2 | -16 |
| Net financials | 1.731 | -157 | -1.603 | -1.032 | -67 | 1.198 | 1.855 | 1.604 | 2.101 | 220 | -434 | -2.086 | -2.044 |
| Profit before tax | 1.727 | -155 | -1.603 | -1.032 | -81 | 1.198 | 1.852 | 1.598 | 2.049 | 208 | -448 | -2.087 | -2.059 |
| Tax | -0 | -0 | 0 | -2 | -0 | 17 | -1 | -11 | -14 | -8 | 0 | -0 | -0 |
| Net profit | 1.728 | -155 | -1.603 | -1.031 | -81 | 1.181 | 1.852 | 1.609 | 2.063 | 216 | -448 | -2.087 | -2.059 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.098 | 2.986 | 1.513 | 482 | 2.293 | 3.476 | 5.744 | 5.521 | 7.449 | 6.620 | 6.186 | 4.151 | 2.076 |
| Equity | 3.087 | 2.932 | 1.329 | 298 | 2.101 | 3.230 | 5.029 | 4.639 | 6.277 | 6.437 | 5.931 | 3.786 | 1.726 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 | 54 | 184 | 184 | 192 | 246 | 714 | 882 | 1.171 | 183 | 254 | 366 | 349 |
| Total debt | 11 | 54 | 184 | 184 | 192 | 246 | 714 | 882 | 1.171 | 183 | 254 | 366 | 349 |
EBITDA margin
-1579800.0%
This company
15.8%
Market median
-9998834% vs market
20122024
Equity ratio
83.2%
This company
38.2%
Market median
+118% vs market
20122024
Return on equity
-119.3%
This company
18.4%
Market median
-748% vs market
20122024
Net profit margin
-205930600.0%
This company
8.1%
Market median
-2542353186% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMA HOLDING ApS 
LIFE MEDICAL ApSBoard members of PHARMA HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|